ÉTUDE PRODIGE 79-GERCOR-DAVIRIPAC - Abandonné

Title

A multicenter, randomized, open-label, non-comparative 2-stage clinical trial to evaluate the efficacy of DAV132 to prevent dose-limiting irinotecan-induced diarrhea in patients with advanced pancreatic adenocarcinoma treated with FOLFIRI.3 as third-line therapy

Coordonateur